Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study

• Published in: Heart rhythm Vol. 14; no. 7; pp. 955 - 961
• Main Authors: Nasir, Javed M., Pomeroy, William, Marler, Adam, Hann, Matthew, Baykaner, Tina, Jones, Ronald, Stoll, Richard, Hursey, Katherine, Meadows, Angela, Walker, Jennifer, Kindsvater, Steve
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2017
• Subjects: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants - administration & dosage; Atrial fibrillation; Atrial Fibrillation - complications; Atrial Fibrillation - diagnosis; Atrial Fibrillation - drug therapy; Atrial flutter; Device-detected atrial fibrillation; Electrodes, Implanted; Female; Humans; Insertable cardiac monitor; Male; Mass Screening - instrumentation; Mass Screening - methods; Monitoring, Physiologic - instrumentation; Monitoring, Physiologic - methods; Outcome Assessment (Health Care); Prognosis; Propensity Score; Prospective Studies; Risk Assessment - methods; Screening; Thromboembolism - etiology; Thromboembolism - prevention & control; United States - epidemiology; Screening; Insertable cardiac monitor; Device-detected atrial fibrillation; Atrial fibrillation; Atrial flutter
• ISSN: 1547-5271; 1556-3871; 1556-3871
• DOI: 10.1016/j.hrthm.2017.04.026

Atrial fibrillation (AF) is the most common clinically significant cardiac rhythm disorder. There is considerable interest in screening for AF, as it is a leading cause of stroke, and oral anticoagulants (OACs) have been shown to significantly reduce the risk of stroke in patients with AF. Improved...